Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Visum Pharma Logo
Visum Pharma Growth Score
47
CB Rank
158608
Heat Score
46
Visum Pharma is a pharmaceutical company that develops therapeutics for treatment in the areas of neurodegeneration and cancer.
Founded
obfuscation
PrivateSeed Stamford, Connecticut, United States11-50 visumpharmainc.com/
Health Care
Pharmaceutical
Therapeutics
Wellness
Overview

Visum Pharma
Total Funding
obfuscation
Growth Score
47
Heat Score
46

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score47
-7 pts
in past quarter
Heat Score 46
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Visum Pharma

CB Rank
158608
Visum Pharma is a pharmaceutical company that develops therapeutics for treatment in the areas of neurodegeneration and cancer.
Founded
obfuscation
PrivateSeed Stamford, Connecticut, United States11-50 visumpharmainc.com/
Health Care
Pharmaceutical
Therapeutics
Wellness

Funding Rounds

Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Details

Legal Name Visum Pharma, Inc
Operating Status Active
Company Type For Profit
About the Company
Visum Pharma is a pharmaceutical company that develops therapeutics for treatment that focus on the areas of neurodegeneration and cancer. Its technology focuses on normalizing the activity of key signaling nodes, irrespective of the precise causation or genetic underpinnings of the disease, and represents tipping points in the disease process.
Phone Number +1 9146735570
Contact Email msmith@visumpharmainc.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Therapeutics for Neurodegenerative Diseases
Develops pharmacological agents aimed at reducing microglial activation and synaptic loss in neurodegenerative diseases such as Alzheimer's and ALS.
LIN28-Targeting Oncology Therapeutics
Develops pharmacological agents to downregulate LIN28 protein, aiming to improve cancer treatment outcomes by targeting cancer stem cell properties and therapy resistance.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Visum Pharma Logo
Seed Round - Visum Pharma
—
obfuscation
— Seed
obfuscation
Seed Round - Visum Pharma Logo
Seed Round - Visum Pharma
—
obfuscation
— Seed
obfuscation
Seed Round - Visum Pharma Logo
Seed Round - Visum Pharma
—
obfuscation
— Seed
obfuscation
Seed Round - Visum Pharma Logo
Seed Round - Visum Pharma
—
obfuscation
— Seed
obfuscation
Seed Round - Visum Pharma Logo
Seed Round - Visum Pharma
—
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Visum Pharma Logo
Seed Round - Visum Pharma
—
obfuscation
— Seed
obfuscation
Seed Round - Visum Pharma Logo
Seed Round - Visum Pharma
—
obfuscation
— Seed
obfuscation
Seed Round - Visum Pharma Logo
Seed Round - Visum Pharma
—
obfuscation
— Seed
obfuscation
Seed Round - Visum Pharma Logo
Seed Round - Visum Pharma
—
obfuscation
— Seed
obfuscation
Seed Round - Visum Pharma Logo
Seed Round - Visum Pharma
—
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50
News
Technology
View Tech Report

IT Spend

$256.1KThis year, Visum Pharma is projected to spend $256.1K on IT, according to Aberdeen.

Active Website Tech Count

17Visum Pharma is actively using 17 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  Apple Mobile Web Clips Icon.
Sub-Organizations
Frequently Asked Questions

Where is Visum Pharma's headquarters? Visum Pharma is located in Stamford, Connecticut, United States.When was the last funding round for Visum Pharma? Visum Pharma closed its last funding round on
obfuscation
from a Seed round.Who are Visum Pharma's competitors? Alternatives and possible competitors to Visum Pharma may include The Jackson Laboratory, NeuroSense Therapeutics, and  MOMA Therapeutics.How much funding has Visum Pharma raised to date? Visum Pharma has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|